CClinicalTrials.gg
Status unknownNCT02860312Updated Aug 9, 2016

Long Term Physical Activity for Hemodialysis Patients

An interventional study of Intradialytic exercise on stationary bicycles and Non-exercising group in End Stage Renal Disease on Hemodialysis, sponsored by AURA Sante. Status unknown. Open to participants aged 20 Years to 90 Years. Per ClinicalTrials.gov, last updated 2016-08-09.

Sponsored by AURA Sante · Not applicable, Interventional, and Treatment

The sponsor has not verified this record recently (last verified Aug 2016), so the status shown — last known as Not yet recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
100
Allocation
Randomized
Ages
20 Years to 90 Years
Sex
All
01

Study summary

Patients on chronic hemodialysis present severe physical dysfunctioning associated with a significant reduction of their muscle mass. These two parameters are associated with increased morbidity and mortality along with deconditioning and poor quality of life. There are several studies- usually short term, single center uncontrolled and underpowered- that have shown a significant improvement of the physical, metabolic and dialytic parameters.

There are only few studies that have measured the impact of a long term intradialytic exercise intervention on a supervised manner. This is a multi-center controlled study examining the effects of intradialytic cycling on parameters of physical functioning, body composition, cardiovascular and nutritional status, immunological status and quality of life in a group of clinically stable hemodialysis patients

Read the detailed description

General Context Chronic Kidney Patients (CKD) live a sedentary life. Sedentarity and Sarcopenia worsen during the evolution of CKD with numerous cardiovascular diseases, infectious and other comorbidities. Inactivity may activate and amplify the inflammatory process, hypercoagulability, malnutrition, invoking a vicious circle of further inactivity and deconditioning.

These populations have a very low physical activity profile due to important tiredness, perturbed general condition and bad adaptation in effort. The patients with cardiovascular problems have additional limitations due to breathlessness associated with congestive cardiac failure and intermittent claudication due to peripheral arteriopathy. At the dialysis stages the tiredness is accentuated after the hemodialysis sessions. The days off dialysis are rarely used for practicing a physical activity.

The deconditioning along with the reduction of the physical activity are leading to a de-socializing progressing in the course of the chronic renal failure. In that way the patient feels more and more isolated with a serious eventual impact on the nutrition status and his quality of life.

Regular physical activity in this population of patients is exerting beneficial effects on insulin resistance, inflammation, dialysis efficiency, nutrition and arterial pressure. It may also reduce the intradialytic hypotensive episodes and improve quality of life, without side effects.

The objective of this study is to investigate an improvement of the physical functioning associated with a reprogramming of the autonomous nervous system, a reduction of the pro-inflammatory factors with a reduction of the insulin resistance (reduction of the metabolic syndrome), along with improvements on the immune system functioning for hemodialysis patients participating on a one year intradialytic physical activity program.

Principal objective :

The principal aim of the present study is to show the efficacy of intradialytic physical activity on functional capacity with the sit-to-stand test in 60 seconds (STS60) and the time to perform 5 complete sit-to-stand movements (STS5) along with a 6 minutes' walk test (6MWT).

Secondary objectives :

The secondary objectives are the amelioration of parameters associated with cardiovascular, sympathetic or autonomous nervous system, immune, nutritional, metabolic and inflammatory outcomes among with quality of life.

This is a multicenter, controlled randomized trial

Study description:

Inclusion of patients willing to participate in the study, and consequently their randomization in 2 groups.

The intervention group will benefit from a supervised physical activity during the dialysis session and the other group will carry on with his usual physical activities and have the same tests before and after the trial without undergoing a supervised intradialytic physical activity program

Primary judgment criteria :

The principal criteria will be the effect of an aerobic training program with a warming up phase, followed by 30 minutes of intradialytic cycling on 55% of the VO2max, 3 times a week.

The primary judgement criteria will be the improvement of the Sit-to-stand test in 60 seconds (STS60) and the time to complete 5 sit-to stand movements (STS5) as well as the 6 minutes' walk test (6MWT) from T0 (before the training program) to T12 (12 months after the start of the training period)

Secondary criteria:

  • Quality of life parameters evaluated from the questionaries SF36 (The Short Form (36) Health Survey), Borg scale, EVA.
  • Physical activity levels: IPAQ (international physical activity questionary).
  • Body composition (Fat mass, lean mass, bone mineral density, estimation of the muscular mass) with DEXA (dual-energy x-ray absorptiometry).
  • Cardiovascular parameters : Cardiac echography, doppler of the carotid arteries and the lower extremity arteries, 24h cardiac rhythm exploration
  • Immune parameters: leucocyte subpopulation functioning
  • Nutritional and metabolic parameters: weight, BMI, albumin, pre-albumin, pre- and post-dialytic serum urea and creatinine levels, nPCR (normalised Protein catabolic Rate).
  • Inflammatory parameters :(Interleucin) IL1 bêta, IL6, IL8, IL-10, TNF alpha (Tumor necrosis factor alpha), CRP (C reactive protein)
  • Dialysis parameters : Kt/v, anemia control : Hemoglobin (Hb), MCV (mean corpuscular volume), ferritin, erythropoetin dosage (EPO).
  • Number, etiology and duration of hospitalisations
  • Survival in 1 year

Number of participants : 100, ie 50 per group

Layout of the study :

Inclusion of the patient, evaluations at the start of the study protocol, at 6 months and at the end -12 months (M0, M6, M12).

Benefits and risks of this study :

Improvement of functional aerobic capacity, inflammatory status and quality of life. Improvements on the state of pain, autonomy, augmentation of the lean mass with conservation of the muscular mass for the lower extremities and reduction of the total fat mass are expected as well as improvement of the nutritional status, dialysis parameters, anemia control.

The risks are of cardiovascular origin: a possible decompensation of coronary artery disease, peripheral artery disease, taking into consideration that all patients benefit from echo doppler arterial control before the start of the study.

Regular Perdialytic Activity during Dialysis is practiced in AURA Auvergne (Association pour l'Utilisation du Rein Artificiel Santé) since 2 years; there has been no secondary vascular problem associated with the supervised physical activity. Nevertheless, rare tendon problems or articular and muscular pains could be possible on the course of the study

02

Conditions studied

  • End Stage Renal Disease on Hemodialysis
03

In context

Kidney Failure, Chronic

2,085 studies on the registry are indexed under Kidney Failure, Chronic; 260 are open to participants now.

This study's planned enrollment of 100 is above the median of 55 across 1,557 interventional studies indexed under Kidney Failure, Chronic.

Browse Kidney Failure, Chronic studies →

Lead sponsor

This is the only study on the registry with AURA Sante as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
20 Years to 90 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Consenting active hemodialysis patients since at least 6 months aged between 20 and 90 y.o.

Exclusion criteria

Exclusion Criteria:

  • Unstable angina,
  • severe left ventricular dysfunction,
  • Ejection fraction \< 30%,
  • severe peripheral arterial disease,
  • lower extremity amputation,
  • impossibility of physical effort: pain, uncontrolled bone/muscular disease,
  • participation on another study.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
100 participants (estimated)

Study arms

  • Active comparator
    Exercisers

    Intradialytic exercise on stationary bicycles

    Behavioral: Intradialytic exercise on stationary bicycles

  • Placebo comparator
    Non Exercisers

    No intradialytic exercise

    Behavioral: Non-exercising group

Interventions

  • BehavioralIntradialytic exercise on stationary bicycles

    Patients are exercising for 30-60 min during dialysis on an Rated Perceived Exertion (RPE) Scale between 12 and 14

  • BehavioralNon-exercising group

    Patients are having their usual physical activity

06

What researchers measure

Primary outcomes

  1. Improvement of the distance covered after walking for 6 minutes (6 minutes walk test)

    The principal aim of the present study is to show the efficacy of intradialytic physical activity on the improvement of the physical capacity of the patients assessed with the 6 minutes walk test ((6MWT)

    Time frame: 12 months

Secondary outcomes

  1. Quality of life parameters 1

    Quality of life parameters evaluated from the questionnaire SF36 QD

    Time frame: 12 months

  2. Quality of life parameters 2

    Quality of life parameters evaluated from the questionnaire Borg scale

    Time frame: 12 months

  3. Quality of life parameters 3

    Quality of life parameters evaluated from the EVA scale

    Time frame: 12 months

  4. Physical activity levels

    Physical activity levels from the questionnary IPAQ (international physical activity questionnairy)

    Time frame: 12 months

  5. Body composition

    Body composition (Fat mass, lean mass, bone mineral density, estimation of the muscular mass) with DEXA ccanning and bioimpendance

    Time frame: 12 months

  6. Cardiovascular parameters

    Cardiovascular parameters : Cardiac echography, echodoppler of the carotid arteries and the lower extremity arteries, 24h cardiac rythm exploration

    Time frame: 12 months

  7. Immune parametres

    Immune parametres: leucocyte subpopulation fonctioning

    Time frame: 12 months

  8. Nutritional and metabolic parameters 1

    BMI

    Time frame: 12 months

  9. Nutritional and metabolic parameters 2

    serum albumin levels

    Time frame: 12 months

  10. Nutritional and metabolic parameters 3

    serum prealbumin levels

    Time frame: 12 months

  11. Nutritional and metabolic parameters 4

    pre and post dialytic serum urea levels

    Time frame: 12 months

  12. Nutritional and metabolic parameters 5

    pre and post dialytic serum creatinine levels

    Time frame: 12 months

  13. Nutritional and metabolic parameters 6

    nPCR (normalised Protein Catabolic Rate)

    Time frame: 12 months

  14. inflammatory parameters 1

    IL1 bêta

    Time frame: 12 months

  15. inflammatory parameters 2

    IL6

    Time frame: 12 months

  16. inflammatory parameters 3

    IL8

    Time frame: 12 months

  17. inflammatory parameters 4

    IL-10

    Time frame: 12 months

  18. inflammatory parameters 5

    TNF alpha

    Time frame: 12 months

  19. inflammatory parameters 6

    CRP

    Time frame: 12 months

  20. Dialysis parameters

    Kt/V

    Time frame: 12 months

  21. Anemia control 1

    Hemoglobin (Hb)

    Time frame: 12 months

  22. Anemia control 2

    MCV (mean corpuscular volume)

    Time frame: 12 months

  23. Anemia control 3

    Ferritine

    Time frame: 12 months

  24. Anemia control 4

    Erythropoetine dosage (EPO).

    Time frame: 12 months

  25. Number of hospitalisations

    Number of hospitalisations

    Time frame: 12 months

  26. Duration of hospitalisations

    Duration of hospitalisations

    Time frame: 12 months

  27. Survival

    Survival in one year

    Time frame: 12 months

  28. Improvement of Sit to Stand test in 60 seconds (STS60)

    The physical capacity of the patients assessed with the number of cycles performed during a sit-to-stand test in 60 seconds (STS60).

    Time frame: 12 months

  29. Improvement of the time needed to perform 5 Sit to Stand cycles (STS5)

    Time needed to perform 5 Sit to Stand cycles (STS5)

    Time frame: 12 months

07

Study locations

No study locations are listed for this record.

08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Aug 9, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT02860312
Lead sponsor
AURA Sante
Responsible party
Sponsor
First posted
Aug 9, 2016
Start date
Sep 2016
Primary completion
Sep 2018 (estimated)
Completion
May 2019 (estimated)
Last update
Aug 9, 2016

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Aug 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion